Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-01-25
2005-01-25
Helms, Larry R. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C435S326000
Reexamination Certificate
active
06846912
ABSTRACT:
Antibodies to a LAR phosphatase subunit, particularly antibodies having specificity to an intracellular domain of a phosphatase subunit, methods for generation thereof and cells producing these antibodies, and determination and examination methods of LAR/LAR derived molecules using these antibodies, as well as uses of these antibodies in diagnosis and therapy of thyroid cancer are disclosed.
REFERENCES:
patent: 4752583 (1988-06-01), Jensen et al.
patent: 5538886 (1996-07-01), Schlessinger et al.
patent: 5646333 (1997-07-01), Dobres et al.
patent: 5736149 (1998-04-01), Avjioglu et al.
patent: 5837505 (1998-11-01), della-Cioppa et al.
patent: 5888794 (1999-03-01), Schlessinger et al.
patent: 5916561 (1999-06-01), Adolf et al.
patent: 1 097 944 (2001-05-01), None
Ahmad et al (1995, J Clin Invest; 95 :2806-12).*
Ahmad et al (1997, J. Biol. Chem. vol. 272, pp. 448-457).*
Streuli, et al., 1988, J. Exp Med., 168:1523-1530.*
Streuli, et al., 1990, EMBO Journal, 9(8):2399-2407.*
Streuli, et al., 1992, EMBO Journal, 11(3):897-907.*
Furukawa, et al., 1994, Proc. Natl. Acad. Sci, USA, 91:10928-32.*
Supplemental European Search Report for EP 99 92 3958 dated Feb. 18, 2004.
Itoh et al., “Purification and Characterization of the Catalytic Domains of the Human Receptor-linked Protein Tyrosine Phosphatases HPTPβ, Leukocyte Common Antigen (LCA), and Leukocyte Common Antigen-related Molecule (LAR),” J. Bio. Chem. 267:17, pp. 12356-12363, 1992.
Yu et al., “The N-terminal and C-terminal Domains of a Receptor Tyrosin Phosphatase are Associated by Non-covalent Linkage,” Oncogene v. 7, 1051-1057, 1992.
Zhang et al., “LAR Tyrosine Phosphatase Receptor: Alternative Splicing is Preferential to the Nervous System, Coordinated with Cell Growth and Generates Novel Isoforms Containing Extensive CAG Repeats,” J. Cell Bio. 128:3, 415-431, 1995.
Bendayan, Moise, “Possibilities of False Immunocytochemical Results Generated by The Use of Monoclonal Antibodies: The Example of the Anti-proinsulin Antibody,”J. Histochem. Cytochem., 43(9):881-86 (1995).
Besco, et al., “Genomic Organization and Alternative Splicing of the Human and Mouse RPTPp Genes,”BMC Genomics, 2:1-13 (2001).
Yakura, “CD45 Isoforms and Functional Diversity of T and B Cells,”Medical Immunology, 27(4):333-339 (1994). (English translation of Table 1 of p. 334).
U.S. Appl. No. 09/743,492, filed Apr. 30, 2001, Yamamoto, et al.
Bost, et al., “Antibodies against a peptide sequence within the HIV envelop protein crossreacts with human interluekin-2,”Immunol. Invest., 17(6-7):577-86 (1988).
Debant, et al., “The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains,”Proc. Natl. Acad. Sci. U.S.A., 93(11):5466-71 (1996).
Harlow, et al., “Antibodies: A Laboratory Manual,” Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1988).
Hersh, et al., “The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1,”Proc. Natl. Acad. Sci. U.S.A., 96(5):2396-401 (1999).
Zhang, et al., “Molecular Cloning and Expression of a Unique Receptor-Like Protein-Tyrosine-Phosphatase in the Leukocyte-Common-Antigen-Related Phosphatase Family,”Biochem J., 302:39-47 (1994).
Faure et al., “Diagnostic Features of Primary Malignant Lymphomas of the Thyroid with Monoclonal Antibodies,” Cancer(Phila), 61(9):1852-1861 (1988).
Fernando et al., “Antibodies to the Human γ2 Subunit of the GABAa/Benzodiazepine Receptors,” J. Neurochem., 64(3):1305-1311 (1995).
Furukawa et al., “Specific Interaction of the CD45 Protein-Tyrosine Phosphatase with Tyrosine-Phosphorylated CD3 ζ Chain”,Proc. Natl. Acad. Sci. USA, 91:10928-10932(1994).
Goldstein et al., “Regulation of Insulin Receptor Signaling by Protein-Tyrosin Dephosphorylation”,Receptor, 3:1-15(1993).
Osamu Kanemitsu, “Koutai Kougaku Nyuumon,” K.K. Chijin Shokan, 145-166 (1994).
Streuli et al., “Distinct Functional Roles of the Two Intracellular Phosphatase Like Domains of the Receptor-Linked Protein Tyrosine Phosphatases LCA and LAR”,EMBO J., 9:2399-2407 (1990).
Streuli et al., “Expression of the Receptor-Linked Protein Tyrosine Phosphatase LAR: Proteolytic Cleavage and Shedding of the CAM-Like Extracellular Region”,EMBO J., 11:897-907(1992).
Streuli et al., “A New Member of the Immunoglobulin Superfamily That Has a Cytoplasmic Region Homologous To The Leukocyte Common Antigen”,J. Exp. Med., 168:1523-1530(1988).
Takeuchi et al., “Characterization of AE-6 Monoclonal Antibody Recognizing VHCSAGV Sequence in CD45 PTPase Domain,” Tissue Antigens, 42(4):441 (1993).
Konishi Noboru
Tsujikawa Kazutake
Uchino Yukiko
Yamamoto Hiroshi
Fuso Pharmaceutical Industries Ltd.
Helms Larry R.
Marshall & Gerstein & Borun LLP
Yu Misook
LandOfFree
Antibody against LAR phosphatase subunit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody against LAR phosphatase subunit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody against LAR phosphatase subunit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3407704